Evaluating Europe’s Capacity for Medical AI Autonomy

The global paradigm shift toward generative artificial intelligence and foundation models has transformed healthcare research, diagnostic radiology, digital pathology and drug discovery. However, this technological frontier has intensified a critical strategic vulnerability for Europe: a profound structural reliance on United States technology conglomerates for computational hardware, cloud infrastructure, and frontier foundation models. While American technology leaders deploy multi-billion-dollar clusters to train trillion-parameter multi-modal systems, European policymakers and healthcare institutions are navigating a complex operational trilemma. This trilemma pits the mandate for technological data sovereignty and strict regulatory oversight against the operational necessity of accessing state-of-the-art diagnostic and reasoning capabilities.
  
Whether Europe can construct and maintain its own sovereign foundation models for medicine, or if it is structurally locked into permanent reliance on US Big Tech, depends on a nuanced dynamic. Europe cannot win a brute force competition in general purpose large language model (LLM) compute against US hyper scalers. 
  
However, an alternative technological trajectory is emerging. By leveraging dense, structured clinical registries, unified health data frameworks, specialised biology-native architectures, and open weight model strategies, European research ecosystems are carving out a defensible niche in clinical and biological AI.

Strategic Trajectory and Recommendations
  
The analysis indicates that Europe cannot achieve technological self-sufficiency by attempting to replicate the US hyperscaler model of general-purpose, compute-heavy LLMs. The capital intensity, hardware concentration, and cloud footprint of US Big Tech remain unmatchable by public EU budgets alone.
 
However, permanent reliance is not inevitable if European policy and industry stakeholders pivot toward a domain-specific strategy focused on biological intelligence, open-weight architectures, and federated data assets. Europe retains an advantage in scientific research, clinical expertise, and structured patient data repositories.
  
To translate these systemic strengths into sustainable technological autonomy, the European AI ecosystem should prioritise four strategic vectors:
  
Capitalise on Biology-Native AI
  
Rather than allocating scarce public compute toward building localized clones of general text engines, public and private capital should target biology-native reasoning platforms. Domains such as automated biological hypothesis generation, spatial transcriptomics, structural biophysics, and digital pathology represent open frontiers where scientific context matters more than brute-force parameters. Initiatives like Owkin's agentic biological infrastructure demonstrate how European consortia can achieve global leadership in these specialised domains.
  
Accelerate Operationalisation of EHDS Secure Processing Environments
 
EU Member States must prioritise the technical roll-out of the EHDS ahead of the statutory 2029 deadline. Establishing standardised, highly secure APIs and federated SPEs across major academic medical centres will allow European AI developers to train multi-modal models on diverse, population-scale datasets. This will create a data moat that foreign technology firms cannot easily replicate due to strict cross-border data transfer limitations.
  
Harmonise Digital Health Reimbursement Pathways
  
The European Commission and Member State health authorities should establish a unified cross-border HTA framework for medical AI. Building on the foundations of Germany's DiGA and France's PECAN, a "European Mutual Recognition" pathway for software medical devices would allow an AI application validated in one Member State to rapidly gain provisional reimbursement access across the EU. This would dramatically expand the addressable market for homegrown start-ups, attracting the late-stage venture capital needed to scale.
  
Institutionalise Open-Weight and Sovereign Edge Deployment
  
To insulate clinical infrastructure from geopolitical disruptions and cloud vendor lock-in, European healthcare systems should standardise on open-weight foundation architectures deployable on-premise or within sovereign public clouds. Supporting players like Mistral AI in developing domain-specialized, open-weight base models ensures that clinical workflows remain audit-ready, GDPR-compliant, and independent of external API endpoints.
  
By integrating its public supercomputing investments with unified health data access, streamlined regulatory clearance, and domain-specific biological AI research, Europe can establish a resilient, competitive, and sovereign medical AI ecosystem.

Read the report in full https://www.healthcare.digital/single-post/can-europe-build-its-own-foundation-models-for-medicine-or-is-it-permanently-reliant-on-us-big-tech